LEAVITT PARTNERS, LLC

Lobbying for ALLIANCE FOR MRNA MEDICINES · Multi-organization alliance representing the MRNA sector.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

The Alliance for mRNA Medicines (AMM) is dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.